Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

15.46

Margin Of Safety %

Put/Call OI Ratio

0.49

EPS Next Q Diff

-0.02

EPS Last/This Y

1.3

EPS This/Next Y

0.46

Price

47.56

Target Price

53.09

Analyst Recom

1.77

Performance Q

5.52

Relative Volume

0.78

Beta

1.86

Ticker: TWST




20 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2024-12-19TWST43.570.540.043262
2024-12-20TWST47.990.530.063268
2024-12-23TWST48.10.590.472529
2024-12-24TWST48.90.590.052555
2024-12-26TWST49.30.540.062772
2024-12-27TWST48.210.530.102821
2024-12-30TWST47.210.510.042900
2024-12-31TWST46.480.510.242907
2025-01-02TWST45.370.516.292906
2025-01-03TWST47.290.580.413036
2025-01-06TWST48.540.590.223037
2025-01-07TWST45.540.592.473049
2025-01-08TWST45.070.640.293205
2025-01-09TWST45.120.640.283205
2025-01-10TWST43.550.643.143215
2025-01-13TWST43.520.700.153330
2025-01-14TWST42.760.690.023352
2025-01-15TWST45.410.610.013652
2025-01-16TWST45.880.570.023803
2025-01-17TWST47.510.492.634188
DateSymbolLastP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2024-12-19TWST43.6115.3- -2.29
2024-12-20TWST47.9815.3- -2.29
2024-12-23TWST48.1215.3- -2.29
2024-12-24TWST48.9015.3- -2.29
2024-12-26TWST49.2215.3- -2.29
2024-12-27TWST48.2115.3- -2.29
2024-12-30TWST47.2415.3- -2.29
2024-12-31TWST46.5215.3- -2.29
2025-01-02TWST45.3015.3- -2.29
2025-01-03TWST47.2915.3- -2.29
2025-01-06TWST48.5215.3- -2.29
2025-01-07TWST45.6015.3- -2.29
2025-01-08TWST45.1215.3- -2.29
2025-01-09TWST45.1215.3- -2.29
2025-01-10TWST43.5715.3- -2.29
2025-01-13TWST43.4915.3- -2.29
2025-01-14TWST42.7115.3- -2.29
2025-01-15TWST45.4815.3- -2.29
2025-01-16TWST45.8515.3- -2.29
2025-01-17TWST47.5615.3- -2.29
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2024-12-19TWST-3.790.5517.18
2024-12-20TWST-3.790.5517.18
2024-12-23TWST-3.460.5517.22
2024-12-24TWST-3.350.5517.22
2024-12-26TWST-3.670.5515.98
2024-12-27TWST-3.670.5515.98
2024-12-30TWST-3.740.5215.98
2024-12-31TWST-3.840.5215.98
2025-01-02TWST-3.810.5215.94
2025-01-03TWST-3.760.5215.94
2025-01-06TWST-3.550.9915.94
2025-01-07TWST-3.550.9915.94
2025-01-08TWST-3.730.9915.94
2025-01-09TWST-3.730.9915.92
2025-01-10TWST-3.860.9915.92
2025-01-13TWST-3.840.9815.46
2025-01-14TWST-4.000.9815.46
2025-01-15TWST-4.000.9815.46
2025-01-16TWST-4.020.9815.46
2025-01-17TWST-4.020.9815.46
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

-0.59

Avg. EPS Est. Current Quarter

-0.64

Avg. EPS Est. Next Quarter

-0.6

Insider Transactions

-4.02

Institutional Transactions

0.98

Beta

1.86

Average Sales Estimate Current Quarter

86

Average Sales Estimate Next Quarter

90

Fair Value

Quality Score

37

Growth Score

53

Sentiment Score

56

Actual DrawDown %

77.8

Max Drawdown 5-Year %

-94.5

Target Price

53.09

P/E

Forward P/E

PEG

P/S

9.05

P/B

5.92

P/Free Cash Flow

EPS

-3.6

Average EPS Est. Cur. Y​

-2.29

EPS Next Y. (Est.)

-1.84

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-66.69

Relative Volume

0.78

Return on Equity vs Sector %

-63.2

Return on Equity vs Industry %

-54.5

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Twist Bioscience Corporation
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 919
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
stock quote shares TWST – Twist Bioscience Corporation Stock Price stock today
news today TWST – Twist Bioscience Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch TWST – Twist Bioscience Corporation yahoo finance google finance
stock history TWST – Twist Bioscience Corporation invest stock market
stock prices TWST premarket after hours
ticker TWST fair value insiders trading